Decreased plasma levels of amitriptyline and its metabolites on comedication with an extract from St. John's wort (Hypericum perforatum)

Journal of Clinical Psychopharmacology

Volumn 22, Issue 1, 2002, Pages 46-54

  Johne, Andreas ^a   Schmider, Jürgen ^a   Brockmöller, Jürgen ^a   Stadelmann, Andreas M ^a   Störmer, Elke ^a   Bauer, Steffen ^a   Scholler, Gudrun ^a   Langheinrich, Matthias ^a   Roots, Ivar ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ATORVASTATIN; BENZOCAINE; CONJUGATED ESTROGEN; CYCLOSPORIN; CYTOCHROME P450; DIGOXIN; DRUG METABOLITE; ETHINYLESTRADIOL; HYDROCHLOROTHIAZIDE; HYPERFORIN; HYPERICIN; HYPERICUM PERFORATUM EXTRACT; INDINAVIR; LEVONORGESTREL; METOPROLOL; NORTRIPTYLINE; PSEUDOHYPERICIN; RAMIPRIL; THIAMAZOLE; THYROXINE; TICLOPIDINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONSTIPATION; DEPRESSION; DRUG BLOOD LEVEL; DRUG INDUCED DISEASE; DRUG METABOLISM; FATIGUE; FEMALE; HEADACHE; HERBAL MEDICINE; HUMAN; MALE; MENTAL DISEASE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; TREATMENT OUTCOME; VISUAL IMPAIRMENT; XEROSTOMIA;

ADULT; AMITRIPTYLINE; DEPRESSIVE DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERICUM; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; NORTRIPTYLINE; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 0036157182     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200202000-00008     Document Type: Article

References (48)

1. Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey
2. Grapefruit juice-drug interactions
3. Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum)
4. Interaction of St. John's wort extract with phenprocoumon
5. Indinavir concentrations and St John's wort
6. Acute heart transplant rejection due to Saint John's wort
7. Psychopharmaka
8. A systematic review of newer pharmacotherapies for depression in adults: Evidence report summary
9. Placebo-controlled double-blind study examining the effectiveness of an hypericum preparation in 105 mildly depressed patients
10. LI 160, an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients - A controlled 6-week clinical trial
11. Comparison of St John's wort and imipramine for treating depression: Randomised controlled trial
12. Equivalence of St John's wort extract (Ze 117) and fluoxetine: A randomized, controlled study in mild-moderate depression
13. Biologically active and other chemical constituents of the herb of Hypericum perforatum L
14. Hyperforin as a possible antidepressant component of hypericum extracts
15. Solubilized hypericin and pseudohypericin from Hypericum perforatum exert antidepressant activity in the forced swimming test
16. Hypericism
17. Hypericin and pseudohypericin: Pharmacokinetics and effects on photosensitivity in humans
18. Column switching and high-performance liquid chromatography in the analysis of amitriptyline, nortriptyline and hydroxylated metabolites in human plasma or serum
19. Determination of hyperforin, hypericin, and pseudohypericin in human plasma using high-performance liquid chromatography analysis with fluorescence and ultraviolet detection
20. Cytochrome P450 2D6 variants in a Caucasian population: Allele frequencies and phenotypic consequences
21. Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications
22. Identification of new human CYP2C19 alleles (CYP2C19*6 and CYP2C19*2B) in a Caucasian poor metabolizer of mephenytoin
23. Amitriptyline pharmacokinetics and clinical response: I. Free and total plasma amitriptyline and nortriptyline
24. Single-dose and steady-state pharmacokinetics of hypericin and pseudohypericin
25. Potential metabolic interaction between St. John's wort and theophylline
26. Safety of St John's wort (Hypericum perforatum)
27. Urinary β-hydroxycortisol excretion rate is affected by treatment with Hypericum perforatum
28. St John's Wort: Effect on CYP3A4 activity
29. St. John's wort induces intestinal p-glycoprotein/MDR1 and intestinal and hepatic CYP3A4
30. Hazardous pharmacokinetic interaction of Saint John's wort (Hypericum perforatum) with the immunosuppressant cyclosporin
31. Five distinct human cytochromes mediate amitriptyline N-demethylation in vitro: Dominance of CYP 2C19 and 3A4
32. N-demethylation of arnitriptyline in vitro: Role of cytochrome P-450 3A (CYP3A) isoforms and effect of metabolic inhibitors
33. Enzyme kinetic modelling as a tool to analyse the behaviour of cytochrome P450 catalysed reactions: Application to amitriptyline N-demethylation
34. E- and Z-10-hydroxylation of nortriptyline: Relationship to polymorphic debrisoquine hydroxylation
35. Enantioselective amitriptyline metabolism in patients phenotyped for two cytochrome P450 isozymes
36. Nortriptyline E-10-hydroxylation in vitro is mediated by human CYP2D6 (high affinity) and CYP3A4 (low affinity): Implications for interactions with enzyme-inducing drugs
37. Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to mdr1a p-glycoprotein gene disruption
38. Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo
39. Competitive, non-competitive and cooperative interactions between substrates of P-glycoprotein as measured by its ATPase activity
40. Reversal of multidrug resistance by amitriptyline in vitro
41. Discrepancies between pharmacokinetic studies of amitriptyline
42. Effects of carbamazepine on serum antidepressant concentrations in psychiatric patients
43. The use of therapeutic drug monitoring data to document kinetic drug interactions: An example with amitriptyline and nortriptyline
44. Time course of enzyme induction in humans: Effect of pentobarbital on nortriptyline metabolism
45. Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression
46. St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor
47. St John's wort, a herbal antidepressant, activates the steroid X receptor
48. CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: A first step towards subpopulation-specific dosages